Question of the Day – Thursday February 2, 2017
Question: What is the prevalence rate for intentional volatile solvent use/abuse among American adolescents?
Question of the Day – Wednesday February 1, 2017
Question: What are the landmark principles regarding expert testimony as established by the well-known case of Daubert v Merrell Dow Pharmaceuticals, Inc.?
Question of the Day – Tuesday January 31, 2017
Question: The aromatic amine 4-aminobiphenyl (4-ABP) is present in tobacco smoke. The development of which human cancer has been liked to exposure to this chemical?
Question of the Day – Monday January 30, 2017
Question: The recognition of chemicals as potential carcinogens had its inception with observations made by Sir Percival Pott in the 1770’s. What was this individual’s contribution to the science of chemical carcinogenesis?
Question of the Day – Friday January 27, 2017
Question: What are the primary environmental sources for the chemical sulfur dioxide?
Question of the Day – Wednesday January 25, 2017
Question: Who were the “radium girls”?
Question of the Day – Tuesday January 24, 2017
Question: What is the classic presentation of tick paralysis?
Question of the Day – Monday January 23, 2017
Question: What is “nanging” and what clinical symptoms may result from repeated nanging?
Question of the Day – Friday January 20, 2017
Question: Individuals requiring chronic transfusion therapy are often treated with the iron chelator deferoxamine in order to address transfusion-induced hemochromatosis and associated complications. Which toxicities have been associated with the use of deferoxamine?